Biologics in psoriatic arthritis: where we are and where we are headed Presented ByDr Vinod Chandran ConferenceIFPA 2024 TypeNews article 17 July 2024 11:55
Primary endpoint of opicinumab for relapsing MS not met in AFFINITY trial Presented ByProf. Peter Calabresi, Johns Hopkins University, MD, USA TrialPhase 2, AFFINITY ConferenceECTRIMS 2021 TypePeer-reviewed article 9 December 2021 14:12